Sunday, August 31, 2025

< + > Bonus Features – August 31, 2025 – 85% of health plans still haven’t integrated internal and external data for analytics, 70% of Americans say inflation negatively impacts access to care, plus 24 more stories

Welcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s so much happening out there in healthcare IT we aren’t able to cover in our full articles, we still want to make sure you’re informed of all the latest news, announcements, and stories happening to help you better do your job.

News and Studies

Partnerships

Products

People

If you have news that you’d like us to consider for a future edition of Healthcare IT Today Bonus Features, please submit them on this page. Please include any relevant links and let us know if news is under embargo. Note that submissions received after the close of business on Thursday may not be included in Bonus Features until the following week.



Saturday, August 30, 2025

< + > Weekly Roundup – August 30, 2025

Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing a look back at the articles we posted and why they’re important to the healthcare IT community. We hope this gives you a chance to catch up on anything you may have missed during the week.

Relieving Sinus Congestion With a Headband. John Lynn connected with Paramesh Gopi at SoundHealth, which makes the SONU headband that sends vibrations to each of the six sinus cavities with effects similar to anti-allergy medications. Read more…

Enhancing Payer-Provider Collaboration to Address Population Health Challenges. How is the Healthcare IT Today community doing this? Unified data platforms, integrate workflows and real-time analytics are some of the most effective strategies. Read more…

Is Your Revenue Cycle a Disaster? John summarized an eBook from TempDev about how to avoid common RCM challenges such as increased denials and mismanaged patient collections. Read more…

Driving Toward N=1 Healthcare. Colin Hung sat down with Mike Serbinis at League, which is helping health systems analyze data to recommend a patient’s next steps. The key is to just get started, he said; AI can work with messy datasets, and there’s no such thing as a perfect dataset. Read more…

Life Sciences Today Podcast: Predicting Therapeutic Response. Miha Štajdohar at Genialis connected with Danny Lieberman to discuss the benefits of predictive models in cancer treatment. Read more…

CIO Podcast: Digital Messaging. Tom Gillette at Mount Sinai Medical Center joined John to discuss whether interest in digital messaging will keep growing at its post-pandemic pace. They also touch on how to support non-English speaking populations with digital messaging tools. Read more…

Digital Health Is Getting a Reality Check, and That’s a Good Thing. Julien de Salaberry at Galen Growth spelled out how the size and quality of digital health funding deals is rising. That’s s sign the industry is moving away form hype and closer to validated results. Read more…

How Assistive and Adaptive Tools Work Together to Transform Care. Assistive technologies help individuals perform everyday tasks, while adaptive technologies modify existing technology. Both can enable more inclusive and personalized care, according to Roland Mattern at eSight by Gentex. Read more…

How Legacy Data Boosts Efficiency in Cardiac Care. Platforms can help clinicians manage data from implantable cardiac monitors – but only if data integrity issues can be solved prior to implementation, noted Christy Brickers at MURJ. Read more…

Bridging the Gap Between Hospital Data and Medical AI. Benji Meltzer at Gradient Health outlined how data intermediaries take fragmented, real-world data and turn it into something usable, which has clear benefits for care delivery and medical research. Read more…

This Week’s Health IT Jobs for August 27, 2025: Roles in clinical data management, privacy, and value-based care. Read more…

Bonus Features for August 24, 2025: 71% of patients turn to WebMD post-diagnosis; meanwhile, OptimizeRx makes big changes in its leadership team. Read more…

Funding and M&A Activity:

Thanks for reading and be sure to check out our latest Healthcare IT Today Weekly Roundups.



Friday, August 29, 2025

< + > Therapeutic Response with Genialis – Life Sciences Today Podcast Episode 24

We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Miha Štajdohar, Co-Founder and CTO at Genialis. Genialis develops and markets an AI supermodel that can predict Therapeutic Response for cancer patients.

Check out the main topics of discussion for this episode of the Life Sciences Today podcast:

  • Tell me about your journey to Genialis?
  • Who are your customers?
  • How do you create value for your customers?
  • How do you capture value from them?
  • What are 3 things you want to achieve for your customers in the next 12-18 months?

Now, without further ado, we’re excited to share with you the next episode of the Life Sciences Today podcast.

 

Be sure to subscribe to the Life Sciences Today on your favorite podcasting platform:

Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube.  Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.

If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.

Thanks so much for listening!



< + > Beyond the Buzz: Digital Health Needs a Reality Check—And That’s a Good Thing

The following is a guest article by Julien de Salaberry, CEO at Galen Growth

For much of the past decade, digital health has enjoyed the spotlight. Fueled by pandemic urgency, investor exuberance, and a proliferation of new technologies, the space saw record-breaking funding rounds, skyrocketing valuations, and breathless headlines about how AI, wearables, and telemedicine would reinvent healthcare overnight.

But as we enter the second half of 2025, the tone has changed. That’s not a bad thing. In fact, it’s necessary.

Our latest Q2 2025 Digital Health Funding Trends report at Galen Growth confirms what many in the sector have suspected: we’ve reached a turning point. Global digital health funding totaled $12.1 billion in the first half of the year, a 13% decline compared to H1 2024. At first glance, that may seem like a setback. But beneath the surface, something far more interesting is happening.

While the number of deals is falling, the size and quality of those deals are rising. Late-stage financings are up 1.6x year-over-year. AI-powered ventures that can demonstrate cost reduction, workflow efficiency, or improved clinical outcomes are attracting outsized attention. Health Management Solutions alone captured 23% of all venture funding and 18% of new partnership announcements, more than any other cluster in the ecosystem.

The message is clear: the market is no longer interested in moonshots or prototypes. Investors want performance. Hospital systems want integration. And patients want solutions that work.

This is not a “cooling” of digital health; it’s a refinement. The days of “spray and pray” investing are over. Now, capital is flowing toward companies with clinical validation, scalable platforms, and clearly defined pathways to reimbursement and revenue. AI solutions are at the center of this shift, especially those that deliver a “productivity premium” by shortening care journeys or reducing provider burnout.

We’re also seeing a change in how partnerships form. Corporations and providers are entering fewer collaborations, but those partnerships are more strategic and implementation-focused. The high-profile dissolution of Novo Nordisk’s deal with Hims & Hers is a cautionary tale: brand alignment is not enough. Outcomes matter.

This market discipline is a healthy correction. It separates hype from substance and forces innovators to prove their value. And while some early-stage ventures may struggle, the ones that survive will be better equipped to deliver long-term impact.

We need to move past the obsession with “the next big thing” and instead focus on what creates real, measurable improvement in healthcare. The digital health sector must now mature into the system-changing force it always promised to be. This is a moment of evolution, not contraction.

There’s no doubt that challenges remain. The IPO window remains narrow. Many scale-ups will need to raise capital again within 12 to 18 months, often at flatter valuations. But those that can prove their clinical and economic value will find backing.

Digital health doesn’t need another hype cycle. It needs results. And finally, it’s being asked to deliver.



< + > Supreme Group Acquires Pivot Design, Marking a Significant Expansion in Pharma and Rare Disease

Ninth Acquisition in 18 Months Adds Brand, Creative, and Omnichannel Strength to Supreme Group’s Rapidly Growing Healthcare and Life Sciences Marketing Platform

Supreme Group, a next-generation agency platform purpose-built for healthcare and life sciences marketing and communications, today announced it has acquired Pivot Design, a globally recognized agency known for infusing health brands with humanity and bold storytelling. This latest milestone marks Supreme Group’s ninth acquisition in just 18 months, reflecting the company’s momentum and continued investment in building an unmatched collective of talent and capabilities to deliver client impact.

With Pivot Design, Supreme Group significantly expands its leadership in pharma and rare disease, gaining a team celebrated for translating complex science into breakthrough brand experience. Pivot’s legacy spans three decades of helping healthcare innovators connect with patients and professionals through strategy, creative excellence, and omnichannel campaigns that drive real-world change.

Pivot Design’s reputation for breaking through complexity with empathy and creativity has made it a trusted partner across the healthcare spectrum, and recently earned the agency a finalist spot in MM+M’s Rare Disease Agency of the Year and Best Use of Market Access Marketing.

“We weren’t looking for just any partner, we were looking for the right one,” said Liz Kanter, President at Pivot Design. “Supreme Group shares our values and respects our independence while providing us with powerful tools in AI, technology, and data to help us scale our impact. This acquisition allows us to stay true to who we are, bringing soul to our clients and communities, while evolving within a rapidly changing healthcare landscape.”

Pivot Design will maintain its brand identity and leadership structure, while gaining access to enhanced capabilities and inter-agency collaboration through the connected Supreme Group platform.

“Pivot stands out for its ability to bring clarity and emotional brand connections to some of the most challenging areas in healthcare,” said Tom Donnelly, CEO at Supreme Group. “By welcoming Pivot to Supreme Group, we’re deepening our expertise in rare disease and pharma, and expanding the creative and omnichannel solutions we deliver for our clients. This is about helping healthcare brands break through barriers, move faster, and lead with measurable impact, no matter how complex the challenge.”

With Pivot Design now part of the Supreme Group platform, the company continues to redefine healthcare and life sciences marketing, delivering smarter, faster, and more creative solutions that help brands break through complexity, drive meaningful growth, and make a measurable impact where it matters most.

About Supreme Group

Supreme Group is an integrated platform that is purpose-built for healthcare and life sciences marketing and communications. Backed by Trinity Hunt Partners, we bring together specialized agencies across Brand + Creative, PR + Communications, and Digital Performance—powered by AI, connected by strategy, and built for measurable impact. Supreme Group’s portfolio companies include Supreme Optimization, Clarity Quest, Health+Commerce, BioStrata, Amendola, Curator24, Kadiko, Nimble Works, and Pivot Design. For more information, visit supremegroup.ai.

About Trinity Hunt Partners

Trinity Hunt Partners is a growth-oriented private equity firm with over $2 billion of assets under management, focused on building leading business, healthcare, and consumer services companies. Trinity Hunt’s mission is to provide the talent and strategic, operational, and financial capabilities needed to build entrepreneurial services companies into market leaders. For more information, visit trinityhunt.com.

About Pivot Design

Pivot Design is a creative agency that brings brands to life at the intersection of science, humanity, and soul. For over 30 years, Pivot has partnered with health innovators—from global leaders to powerful startups—to shape brand experiences that are bold, inclusive, and strategically grounded. We translate complexity into clarity, ideas into action, and insights into emotionally resonant stories that inspire connection and drive change. Whether building from the ground up or breaking through in the moments that matter most, we believe that great design doesn’t just move markets—it moves people. Learn more at pivotdesign.com.

Originally announced August 5th, 2025



Thursday, August 28, 2025

< + > SoundHealth’s SONU Device Relieves Congestion

This video is an in-depth exploration of a headband named SONU from SoundHealth, which relieves congestion through stimulation of the nasal cavities. Founder and CEO Paramesh Gopi explains the scientific research that led to SONU, how it uses scans and AI to customize treatment to the individual, and the clinical trials that won FDA recognition for SONU. (Be sure to check out John’s previous review of SONU)

Resonance as the Key to Congestion Relief

Gopi, who has such strong allergic reactions that he can get sinus infections from them, learned of the research by two doctors, Peter Hwang and Bryant Lin, who investigated why singers are much less likely to develop rhinovirus infection than other people. They revealed that singing vibrates sinus cavities in such a way that they suppress the reaction of the sphenopalatine ganglion and the production of mucus that clogs the cavities. The effects of singing can be reproduced by the SONU device.

Gopi describes the science in more detail in this video, along with the computer technology that makes the SONU effective.

Each person has six sinus cavities of unique shapes and sizes. The vibrations from SONU must be tailored to the particular shapes of the individual. This is done through a scan and AI analysis. Vibrations are synthesized from violin and cello sounds.

Gopi also describes the data collected in order to map the person’s sinuses: points on face that don’t change with surgery, aging, etc., such as the edges of eyes and the shape of nostrils. The validity of their data collection was established through comparisons to CT scans.

He stresses that no biometric data is stored in the cloud; it is processed by AI locally to create the treatment plan for the individual. Furthermore, the information is not sufficient to identify an individual.

Trials and FDA Approval

The SONU is a unique device that’s hard for the FDA to classify. To win approval, SoundHealth worked closely with the FDA, which at the time was under pressure to demonstrate the accuracy of its approvals.

A total of ten clinical trials were held, two of them described in detail by Gopi. The research results have been peer-reviewed and published in medical journals. The trial that won them FDA approval required a control group, for which SoundHealth manufactured a totally different device that didn’t use the correct resonances.

Spreading the device

More than 6,000 people now use the SONU band. It requires 15 minutes at a time. Children can also use the device. SoundHealth has demonstrated that the headband’s effects match those of common anti-allergy medications.

Although sales are direct-to-consumer, they are working with providers to market the device, and with payers to cover it. They can boast of a return rate of less than 10%.

Watch the video for more interesting details about this ground-breaking device.

Learn more about SoundHealth: https://soundhealth.life/

Listen and subscribe to the Healthcare IT Today Interviews Podcast to hear all the latest insights from experts in healthcare IT.

And for an exclusive look at our top stories, subscribe to our newsletter and YouTube.

Tell us what you think. Contact us here or on Twitter at @hcitoday. And if you’re interested in advertising with us, check out our various advertising packages and request our Media Kit.

Full Disclosure: SoundHealth provided a free SONU which John uses regularly.



< + > Empowering Patients Through Technology: How Assistive and Adaptive Tools Work Together to Transform Care

The following is a guest article by Roland Mattern, Director of Sales at eSight by Gentex Corporation

In today’s rapidly evolving healthcare landscape, technology is enabling more inclusive, personalized care than ever before. From wearables that enhance vision to custom mobility devices, tech innovations are redefining how individuals with disabilities or health challenges engage with the world around them. At the center of this transformation are assistive and adaptive technologies—tools that, when thoughtfully integrated, offer powerful support and restore independence across a wide range of conditions.

Both technologies have made significant strides in recent years, thanks to breakthroughs in artificial intelligence, data integration, and user-centric design. While assistive technologies are often used to support common tasks and general needs, adaptive technologies take things a step further, customizing support based on the individual. Together, they create a more holistic and effective model of care.

Assistive Technologies: Real-World Innovations Making a Difference

Often used interchangeably with one another, assistive and adaptive technologies play distinct yet complementary roles in healthcare. While both aim to improve patient care and enhance independence, their function and application differ significantly. Assistive technologies are designed to help individuals perform everyday tasks by providing solutions that address specific challenges or limitations, often built specifically to address disabilities. On the other hand, adaptive technologies often modify existing technology to provide solutions designed to meet a patient’s individual needs.

To better understand the impact of these types of innovations, it’s helpful to look at specific tools that illustrate how they are being applied in real-world settings. Here are some examples of assistive technologies available on the market that are pioneering new ways to improve patient accessibility.

  • AI Hearing Aids: Phonak hearing aids leverage advanced AI to enhance the listening capabilities of individuals with hearing loss; with features like automatic sound adjustments and noise reduction, these hearing aids improve speech understanding in challenging environments, such as crowded spaces or noisy backgrounds 
  • Hands-Free Devices: GlassOuse Assistive Device helps people who cannot use technology due to disabilities or limited bodily movement; through their wireless head mouse, individuals can connect and control devices, including mobile phones, computers, tablets, and smart TVs, simply via head movement

Adaptive Technologies: Personalized Tools for Unique Needs

While assistive tools provide broad support for certain disabilities, adaptive technologies can build off and tailor that support to the individual, allowing them to evolve as the patient’s needs change. These tools often evolve with the user and involve collaboration between healthcare providers, engineers, and patients to ensure the best fit. Adaptive technologies range from customized prosthetics and specialized wheelchairs to cochlear implants, each designed to improve the patient’s ability to navigate their environment and perform daily tasks, as their needs change, with greater ease. 

Wearables for Vision Loss

eSight by Gentex is designed to enhance vision for individuals with central vision loss using a high-speed camera and advanced technology, capturing and processing real-time video, to help them see better. eSight is an assistive device that adapts to users with different levels of vision loss and allows them to customize and adjust the settings to fit their specific vision needs as they change. This advanced wearable device enables users to reconnect with loved ones, retain their mobility and independence, and rediscover hobbies.

Prosthetics

Ottobock is a global leader in prosthetic technology, offering a wide range of solutions designed to enhance mobility for individuals with limb differences. Many of Ottobock’s solutions are highly customizable, allowing users to select features like socket design and liners that align with their unique needs and lifestyles.

Wheelchairs

Everest and Jennings wheelchairs are designed to offer improved comfort and posture. Their Tilt-In-Space wheelchair helps people with conditions like cerebral palsy, spinal injuries, or neurological disorders stay comfortable and independent throughout daily activities. These wheelchairs offer customizable features such as adjustable seat angles, headrests, and support cushions to accommodate each user’s specific medical and ergonomic needs as they change.

Complementary Technologies for Personalized Care

Rather than choosing between assistive or adaptive solutions, the most effective care strategies often combine both. By layering general-use technologies with tailored enhancements, healthcare providers can build more robust, personalized systems of support.

For example, someone experiencing vision loss might begin with general assistive tools like magnifiers or screen readers. If those tools fall short in enabling full mobility or function, more advanced adaptive technologies, such as eSight Go, can step in to fill the gap. Similarly, a patient recovering from injury might benefit from both an off-the-shelf communication device and a customized mobility aid, depending on their evolving needs.

When to Use Each Type of Technology

The decision to implement assistive or adaptive technology (or both) depends on several factors:

  • Assistive technology is often best suited for disabilities that are widely experienced, such as hearing loss, and when ease of access and speed of implementation are priorities
  • Adaptive tech is ideal when personalization significantly enhances usability or when patients face complex or evolving needs that require ongoing support

Healthcare providers and caregivers should assess each patient’s condition and goals to determine the right mix of solutions. When integrated intentionally, assistive and adaptive technologies create a more supportive environment that empowers users and advances overall well-being.

Improving Patient Outcomes Through Assistive and Adaptive Technologies

By removing physical and cognitive barriers, assistive and adaptive technologies help individuals regain control over their lives, fostering a profound sense of independence and confidence. Enhancing the patient experience across various settings, including in-home care and rehabilitation environments, assistive and adaptive technologies play a pivotal role in helping patients regain their mobility and capabilities during recovery or the management of ongoing health conditions. By incorporating these technologies into everyday life, patients can interact more seamlessly with their environment and live more fully.

About Roland Mattern

Roland Mattern, Director of Sales for eSight by Gentex, brings over 30 years of experience in sales and marketing for medical devices and pharmaceuticals, with the past two decades focused on ophthalmology. His unwavering dedication to eSight’s mission—to empower individuals with sight loss through enhanced vision—drives his work. Having spent his career marketing vision-assistive devices, Mattern has witnessed firsthand how companies like eSight are transforming lives and redefining what’s possible for those with visual impairments.



< + > Elion Raises $9.3M for Healthcare AI Research and Intelligence Platform

Backed by NEA, Cedars Sinai Health Ventures, and Other Leading Investors, Elion is Building the Go-To Platform to Help Health Systems Navigate AI Vendor Procurement

Elion, the AI-powered research and intelligence platform for healthcare technology, today announced the close of an oversubscribed $9.3 million seed round. The financing was led by existing Elion investor, NEA, with participation from new investors Cedars Sinai Health Ventures, TMV, Scrub Capital, and Alumni Ventures.

As generative AI and other advanced technologies transform healthcare, provider organizations are under growing pressure to make faster, smarter technology decisions. Yet most lack the structured intelligence, internal expertise, or dedicated resources needed to confidently evaluate an increasingly complex vendor landscape.

Elion is building the trusted platform healthcare leaders rely on for clear, credible insights into emerging technologies and the companies behind them. By combining a structured dataset of thousands of healthcare vendors with deep expertise in the workflows and decision-making dynamics of health systems, Elion delivers fast, high-quality guidance to help provider organizations evaluate solutions with confidence and clarity.

“We’re reimagining what a technology research and advisory business looks like in the age of generative AI,” said Bobby Guelich, Elion’s CEO and Co-Founder. “The starting point is our vendor marketplace, which has quickly become the go-to resource for health systems and provider organizations trying to make sense of a crowded and fast-changing landscape. The depth of our vendor and product intelligence, combined with our ability to deliver it in a structured, accessible format, is helping healthcare leaders make better, faster decisions.”

Elion has seen strong traction, with over 60% of U.S. health systems utilizing its vendor marketplace and a 5x increase in usage over the past year. This engagement reflects growing trust in Elion as a credible resource for health system decision-makers in an increasingly high-stakes technology environment.

“Elion gives me a clear, structured view of the health tech landscape—without the noise. It helps me quickly identify the right partners to advance our digital and innovation goals,” said Tom Maddox, MD SM, Vice President of Digital Products & Innovation at BJC.

Investor enthusiasm has followed Elion’s momentum. “Cedars Sinai Health Ventures is excited to partner with Elion as they empower healthcare leaders with the insights they need to navigate an increasingly complex vendor landscape,” said Maureen Burgess, Partner at Cedars Sinai Health Ventures. “We believe Elion is poised to become a valuable tool for healthtech intelligence—helping hospitals, investors, and innovators make smarter, data-driven choices.”

Joining Cedars Sinai Health Ventures in the round are TMV, Alumni Ventures, and Scrub Capital, a new fund founded by veteran healthcare investors Chrissy Farr, Dr. Rebecca Mitchell, and Dr. Jon Slotkin. Elion also saw strong participation from existing investors, including lead investor NEA, Max Ventures, AlleyCorp, and Floating Point, reflecting continued confidence in its vision and momentum.

“GenAI created a surge of health tech solutions,” said Michael Li, Principal at NEA. “But adoption has lagged as providers face an overwhelming array of high-stakes choices and time-consuming research. Elion accelerates tech adoption and time-to-value so providers can focus on taking care of patients, not applications. We’re thrilled to continue partnering with Bobby and the Elion team as they build the go-to platform for healthcare technology decision-makers.”

The new capital will accelerate platform development, support the launch of new products, and scale Elion’s reach across the healthcare technology ecosystem. To power this next phase of growth, the company is expanding its team across engineering, research, and marketing. With this momentum, Elion is advancing its mission to become the trusted intelligence platform for technology decisions across the healthcare industry.

About Elion

Elion is a trusted health IT marketplace and research firm dedicated to empowering healthcare organizations through technology insights and strategic guidance. By bridging the gap between healthcare leaders and innovative solutions, Elion is driving the future of healthcare delivery.

For more information, visit elion.health

Originally announced August 6th, 2025



Wednesday, August 27, 2025

< + > Enhancing Collaboration Between Payers and Providers in Identifying and Addressing Population Health Challenges

We’ve talked about identifying and addressing population health challenges before, but with it being such a wide topic — there are still plenty of areas that need discussion. Today we are going to focus in on the payer/provider side of population health challenges. We reached out to our wonderful Healthcare IT Today Community to ask — what technologies are being used to enhance collaboration between payers and providers in identifying and addressing population health challenges? The following is what they had to share.

Elevsis Delgadillo, SVP, Customer Success at KeenStack
Technologies like Innovaccer provide a unified data platform that integrates EHRs, claims, labs, and social determinants data into a single patient record. Solutions like this enable payers and providers to identify at-risk populations and implement targeted interventions. Innovaccer was recently selected to support California’s Population Health Management Initiative (PHMI) to help community health centers provide patients with the highest level of care possible. This was a significant step forward in helping providers deliver a coordinated full picture of a patient’s care. When providers can see the full picture of a patient’s health journey, collaboration becomes truly impactful.

Sally Else, President at Mphasis Javelina
Effectively managing population health requires a collaborative ecosystem where both payers and providers can access and act on comprehensive patient and community-level data. A range of enabling technologies is supporting this collaboration, from unified data platforms to advanced analytics and care orchestration tools.

Central to this is the use of integrated data lakes that bring together claims, clinical, social determinant, and behavioral health data. These platforms allow for the generation of 360-degree views of patient populations, facilitating the identification of at-risk cohorts and the tailoring of intervention strategies. Payers and providers can jointly track utilization patterns, chronic disease prevalence, and preventive care adherence. Geospatial analytics tools are also being applied to identify health inequities at the community level, enabling resource planning based on zip-code-level trends.

At the same time, AI-powered tools help in early detection of trends such as readmission risks or prescription non-adherence, triggering timely outreach and support. Cloud-based solutions are increasingly being used to streamline collaboration by enabling secure, role-based access to shared dashboards and care plans. Such platforms enhance transparency, support joint decision-making, and reduce duplication of efforts. Organizations with deep experience in healthcare data integration have implemented platforms that not only support risk stratification and care management but also embed real-time triggers and alerts within workflows. These capabilities ensure that insights are not just retrospective but actionable.

The net impact of these technologies is a more aligned ecosystem, where payers and providers are working from a common set of insights to drive measurable improvements in community health. As population health continues to be central to value-based care strategies, the role of such collaborative, tech-enabled infrastructure will only grow in importance.

Basia Coulter, Partner, Healthcare and Life Sciences at Globant
Technologies like Salesforce Health Cloud are revolutionizing collaboration by providing a unified platform where payers and providers can access and share patient data, care plans, and communication tools. This centralized approach facilitates coordinated care, especially for managing chronic conditions across populations. Additionally, AI, including generative AI, plays a role in analyzing social determinants of health, predicting health trends, and personalizing patient outreach. For instance, Salesforce’s Agentforce for Health utilizes AI to automate tasks like scheduling and eligibility checks, enhancing efficiency in care delivery.

The increasing sophistication of dedicated mobile apps and direct integration with consumer wearables offers another layer. These aren’t just about sharing data with the patient but also about collecting patient-generated health data directly from them. This rich, real-world data can then be aggregated and analyzed for population health insights, providing a more complete picture of lifestyle factors, adherence, and early symptom changes outside of clinical settings.

Michael Gould, AVP of Interoperability Strategy at ZeOmega
FHIR APIs are being put in place by payers and providers to address case management across care teams, reduce administrative burden, and improve the quality of care. Case management enhancements are accomplished through payer or clinical data exchange and collaboration. Administrative burden is reduced through prior authorization and transparency of FHIR APIs. And quality of care measurement is achieved through specific data access patterns performed in bulk for patient populations. While the technology and data specifications are available, payers and providers must continue building trust and evolving workflows to ensure innovations yield benefits for both — and most of all — for patients and populations.

Courtney Yeakel, Chief Product Officer, Payer at Veradigm
Enhancing collaboration between payers and providers is critical in identifying and addressing population health challenges, and it starts with dynamic solutions to share patient data across key pillars of healthcare through trusted, integrated workflows. For example, technology that integrates care gap alerts directly into providers’ electronic health records allows payers to deliver patient-specific notifications within a provider’s existing clinical workflow. With the presentation of these alerts directly in providers’ day-to-day workflows, health plans can significantly reduce care gaps for their beneficiaries, leading to improved health outcomes, reduced costs, and higher quality of care.

All of these results have an impact on greater membership benefits and retention for health plans. With the seamless integration of actionable insights, providers are empowered to address risk and quality care gaps at the point-of-care, leading to enhanced clinical decision-making, stronger patient outcomes, and improved claims acceptance rates substantiated with a complete medical record. Moving forward, we’ll see a continued prioritization of opportunities to innovate, such as including social determinants of health, natural language processing, and transition of care alerts into streamlined workflows. When technology enables payers and providers to improve their collaboration, the healthcare ecosystem as a whole benefits.

Deb Jones, Senior Director, Insights Strategy at Tendo
Population health management has progressed from retrospective claims analysis to real-time, data-driven collaboration. Today, health systems and payers are leveraging integrated care management platforms, patient engagement tools, and advanced analytics dashboards that consolidate data from sources like EMRs, claims, pharmacy records, and social determinants of health. These technologies help align strategies by identifying population health trends, prioritizing at-risk groups, and evaluating intervention effectiveness.

A growing focus is on making population health insights actionable at the point of care, particularly during referrals and care coordination. Workflow-embedded tools and real-time data integration enable care teams to intervene proactively, ensuring timely, patient-centered care decisions. Intelligent analytics and prioritization engines also help surface high-risk populations, support accurate documentation, and measure both clinical and financial outcomes, driving more coordinated, value-based care delivery.

John Weir, Managing Director at BluePath Health
AI is rapidly becoming an indispensable tool for population health management. From stratifying patient populations to predicting high-risk patients in an effort to reduce adverse health outcomes, AI can build upon information shared between providers and payers to enable more precise and efficient resource allocation, targeted care, and patient engagement. For instance, using AI to automate time-consuming identification of patients who are eligible for a diabetes management program and using automation to reach out and enroll them, along with periodic communications to encourage participation and progress. This reduces administrative and operational burden, along with reduced time delays for patients who can benefit from more rapid intervention. At the payer level, improvements with care coordination and more rapid decision making in support of effective and quality healthcare.

Steve Callis, President of Payments at RevSpring
When payers and providers aren’t aligned, patients can feel it. They get multiple bills, unclear messages, and are uncertain about how to ask questions or take action toward their care plan. We’re seeing increased collaboration across the healthcare ecosystem to close those gaps — like securely sharing data, coordinating patient communication, and leveraging both print and digital tools to make the experience more personalized. That kind of care coordination takes work, but it directly influences whether patients take action in their healthcare.

Gary Singh, Senior Director, Product Management at Edifecs (recently acquired by Cotiviti)
Technology is transforming payer-provider collaboration from episodic data handoffs to continuous, real-time intelligence sharing. Key enablers include:

  • EHR Integration APIs: Payers are now accessing structured clinical data directly from provider EHRs to complement their claims-based view, resulting in richer member profiles and improved risk stratification
  • VBC Contract Performance Portals: Providers can log in to dynamic portals that track their performance on cost, quality, and utilization—benchmarking against contract targets and peer performance in near-real-time
  • Utilization Upload Capabilities: Especially under capitation, payers are enabling providers to upload utilization data from non-claims sources (e.g., urgent care or post-acute visits) to enhance care planning accuracy
  • Population Health Intelligence Platforms: These platforms synthesize clinical, financial, and SDOH data to surface actionable trends—such as rising-risk cohorts or high-impact care gaps—allowing both payers and providers to intervene proactively

The key is integration—not just of data but of purpose. Technology is now the connective tissue that enables both parties to act as stewards of population health, not just administrators of care. The most sophisticated implementations utilize AI-powered population health dashboards that provide both organizations with role-based views of shared populations, enabling coordinated intervention strategies and performance tracking.

These platforms incorporate quality measure automation, outcome prediction models, and intervention effectiveness tracking that help organizations continuously refine their population health approaches. Cloud-based analytics platforms with embedded collaboration tools allow distributed teams across payer and provider organizations to work together on population health initiatives, sharing insights and coordinating interventions in real-time regardless of organizational boundaries or geographic locations.

So many great insights here! Huge thank you to everyone who took the time out of their day to submit a quote to us! And thank you to all of you for taking the time out of your day to read this article! We could not do this without all of your support.

What technologies do you think are being used to enhance collaboration between payers and providers in identifying and addressing population health challenges? Let us know what you think over on social media, we’d love to hear from all of you!



< + > Is Your Revenue Cycle Management (RCM) A Disaster?

Whenever I talk with experts in revenue cycle management, it’s amazing to hear them share how almost every hospital, health system, and medical practice has revenue cycle management (RCM) challenges.  I heard one vendor call it revenue leakage which is an apt description for the situation at many healthcare organizations.  In one respect, this means that your healthcare organization isn’t alone.  In another, it means you have a great opportunity to address these RCM challenges and improve the bottom line for your organization.

This is what came to mind when TempDev shared this detailed eBook they created called 5 Disasters in Revenue Cycle Management (RCM) and How to Avoid Them.  Disasters may be overstating it for some organizations, but I guess any loss of revenue that your organization rightfully earned is a disaster.

As I read through the eBook, two of the disasters really stood out for me.  The first one that caught my eye was “Rising Denials and Claim Errors: Stop Draining Your Revenue.”  This one was particularly important to me because I’ve seen it happen so often at organizations.  I’d probably group this disaster into two types: the slow creep and ignorance is bliss.

The slow creep as I call it is those organizations who let their denials and claims errors just slowly deteriorate over time.  They used to have few denials and errors, but over time that number just starts to creep up.  Maybe you hired new staff who aren’t as good, maybe the doctors aren’t documenting as well as they did before, or your staff get distracted by another project and kind of set denials and claims to the side a bit.  Plus, we all know that payers are doing their own slow creep as they deny more claims.  And sometimes it’s a fast creep.

The ignorance is bliss crowd are those that just think that denials and errors are a normal part of doing business.  They don’t realize that their denial and claims error rate could be better.  They’re fine with the status quo and/or don’t realize that it could be better.

Of course, either of these situations is a disaster for an organization that needs that cash flow.  If you check out TempDev’s RCM Disasters eBook, that section of the eBook offers a number of great strategies to address this disaster.  Plus, they show how many of those denials are avoidable.

The other disaster that stood out to me was “Getting Paid: Mastering Patient Collections in Today’s Healthcare Landscape.”  This is a topic we’ve covered a lot here on Healthcare IT Today, so regular readers will be familiar with it.  For a long time, patient collections was kind of an after thought since the majority of cash flow was from payers.  Now with high deductible plans and other changes, patients are shouldering a larger portion of the payment burden.   That’s why mastering patient collections is so important and is a great opportunity for organizations to improve their revenue situation.  I’m glad in the eBook they highlighted this problem and shared some ways to make patient collections a strength for your organization.  It’s a great way to impact your bottom line.

Those are the 2 disasters that stood out to me.  To see the other 3 disasters and to dive deeper into these 2 disasters and what you can do about them, be sure to go and download the FREE eBook by TempDev called 5 Disasters in Revenue Cycle Management (RCM) and How to Avoid Them.

Once you take a look at the 5 disasters they list, let us know on social media what you think of the list and what are some other RCM challenges that you would add to your list.

TempDev is a proud sponsor of Healthcare Scene.



< + > This Week’s Health IT Jobs – August 27, 2025

It can be very overwhelming scrolling though job board after job board in search of a position that fits your wants and needs. Let us take that stress away by finding a mix of great health IT jobs for you! We hope you enjoy this look at some of the health IT jobs we saw healthcare organizations trying to fill this week.

Here’s a quick look at some of the health IT jobs we found:

If none of these jobs fit your needs, be sure to check out our previous health IT job listings.

Do you have an open health IT position that you are looking to fill? Contact us here with a link to the open position and we’ll be happy to feature it in next week’s article at no charge!

*Note: These jobs are listed by Healthcare IT Today as a free service to the community. Healthcare IT Today does not endorse or vouch for the company or the job posting. We encourage anyone applying to these jobs to do their own due diligence.



Tuesday, August 26, 2025

< + > How League is Driving Towards a N of 1 in Healthcare

In healthcare, “personalized” often still means grouping people into broad categories — diabetics, 50-something women, post-op knee patients. League’s goal is different: use good data and AI to shape guidance for each individual, based on their exact health history, behaviors, and preferences.

Mike Serbinis, Founder and CEO of League, has spent decades designing technology for global scale. In healthcare, his focus has zeroed in on a deceptively simple goal: make it possible to engage every patient or member as an audience of one. His approach blends practical fixes for industry bottlenecks with the long-term vision of influencing real behavior change.

Key Takeaways

  1. AI-Driven Personalization Must Reach the “N of 1” Level. Generic protocols won’t cut it—AI can now tailor recommendations for each individual by blending EMR, claims, self-reported, wearable, and synthetic data to drive real action.
  2. Stop Waiting for “Perfect” Data. Health IT leaders often delay engagement initiatives until their data environment is flawless, but that day never comes. Serbinis strongly recommends starting immediately, iterate, and improve as you go.

Personalization Means N of 1

For Serbinis, the future of healthcare lies in an N of 1.

This vision comes from years of building League to become a leader in engaging and encouraging patients as well as members to take the next, most appropriate step in their care/health. That could be booking their next appointment, achieving a dietary goal, keeping up with medications – anything that is aligned to the individual’s care plan or treatment pathway.

“The idea of an N of 1 means leveraging an enormous amount of data,” explained Serbinis.  “Data from internal systems, but also self-reported data, wearable data, and frankly, a lot of synthetic data. All of that is needed to drive personalization that people will actually follow through with.”

That last point is key. The goal isn’t just accurate targeting (which is the goal of broad-based population health initiatives), but to designing outreach that lands with enough relevance to spark a click, a booking, a refill, a lifestyle change.

Serbinis was quick to point out that personalization depends on having usable but not perfect data.

Don’t Wait for “Data Utopia”

To achieve League’s vision of an N of 1 good, but not perfect, health data is required.

“Companies often think they need to wait for this one magical moment where their data is in a perfectly magical state,” Serbinis said. “That never comes. You can’t wait. You have to start.”

Even with incomplete or messy datasets, League is already creating individualized recommendations that get acted on. The precision of those recommendations improves over time as systems and data sources improve. Serbinis strongly recommends starting with what you have already and iterating. “Engagement should start immediately,” he said.

The League Advantage

League’s work shows that effective personalization can be built on existing data assets, even when they are incomplete. As Serbinis noted, “Last year we processed north of a hundred petabytes of data, which is something like 850 years of continuous HD video equivalent… We have a natural and growing advantage to get better at predicting and getting people to engage.”

By starting with the data they have, rather than waiting for a mythical perfect dataset, League has shown that individual-level personalization can happen today, bringing healthcare closer to an N of 1 reality.

Learn more about League at https://league.com/

Listen and subscribe to the Healthcare IT Today Interviews Podcast to hear all the latest insights from experts in healthcare IT.

And for an exclusive look at our top stories, subscribe to our newsletter and YouTube.

Tell us what you think. Contact us here or on Twitter at @hcitoday. And if you’re interested in advertising with us, check out our various advertising packages and request our Media Kit.



< + > Six Data Transfer Insights for Tech Teams: How Legacy Data Boosts Efficiency in Cardiac Care

The following is a guest article by Christy Bricker, CPHIMS, Vice President Strategic Services at MURJ

Effective management of patients with cardiac arrhythmias presents a unique challenge for healthcare providers. Beyond single acute care episodes, these patients require long-term medical monitoring for pacemakers and other Cardiac Implantable Electronic Devices (CIEDs). 

Clinicians follow these patients for many years, whether in person or remotely. Comprehensive and consistent CIED monitoring ensures device safety, delivers continuity of care, and alerts clinicians to new clinical problems.

To achieve these goals efficiently while protecting patients, clinicians require ready access to historical clinical data. This is where legacy data and IT teams become indispensable partners.

The Imperative of High-Quality Legacy Data for Cardiac Device Teams

The traditional landscape of cardiac device monitoring often creates challenges for cardiac device clinic teams, including patchwork processes, overburdened staff, and financial inefficiencies. A significant contributor to these issues is the lack of accessible legacy data within new cardiac device management platforms. This gap in legacy data access and integration leads to several negative impacts:

  • Disrupted Clinical Workflow: Electrophysiologists (EPs) and other clinicians experience disruptions in patient care workflows due to incomplete data
  • Missing Historical Context: Clinicians lack essential historical test data for informed decision-making
  • Manual Data Remediation: Staff often resort to manually cleaning patient data, frequently during patient encounters, which is inefficient and prone to error
  • Wasted EP Time and Errors: Manual data entry consumes valuable clinical time and increases the risk of inadvertent errors

To mitigate these issues, legacy data must be thoroughly cleaned before CIED platform implementation, ideally not during a patient encounter. 

Data Integrity During Data Transfer: Key Considerations for IT Teams

A major challenge in cardiac device management lies in the “unclean” nature of legacy data often housed within feeder systems (the original software platforms where device data was first entered). This can include erroneous or duplicate patient demographic data, device data, inconsistent clinical note formats, and more.

Automated cleaning and transfer of this data are essential; manual entry would consume hundreds of hours for the cardiac device team. Here are six specific insights for IT teams collaborating with cardiac device clinics during new CIED platform implementations:

Addressing Manual Entry Errors

Older systems heavily relied on manual entry for critical data like device serial numbers, leading to frequent errors. Device serial numbers typically range from eight to eleven digits, and many legacy systems lacked automated checks during data entry. 

Navigating Proprietary Databases

Legacy systems often used proprietary databases with configurable structures, complicating data extraction and mapping. Cross-referencing legacy patient data with recent billing data (e.g., last device check within two years) can create a cleaner, more accurate patient list for the go-live.

Combining Technology with Manual Review

Effective transfer of on-premises device data to new platforms necessitates a combination of technology and significant manual review by human operators. This is crucial for accounting for variations in manual entries for device names and other fields. For instance, staff must manually clean data before import to ensure accuracy based on the first few characters of a serial number.

Revealing Patient Activity and Billing Inconsistencies

The cleanup process often reveals that clinics have fewer active patients than initially estimated; only 40-60% of listed patients may be truly active based on their last billed device check within two years. This process also exposes billing inconsistencies, which can lead to a significant uptick in revenue once practices align with appropriate guidelines.

Ensuring Data Accessibility and Accuracy

Proper legacy data transfer ensures historical information is readily available for clinicians, sets up clinics for a smooth go-live, prevents manual entry errors, and results in more accurate discrete data within the existing EHR.

Leveraging FHIR Standards for Integration

The use of FHIR (Fast Healthcare Interoperability Resources) standards can significantly assist IT teams in the data transfer process through deep, bidirectional integration with EHRs. When selecting vendor partners, prioritize those with FHIR capabilities, APIs, HL7 pipelines, preloaded records, and proven go-live playbooks.

Data Migration as a Precursor to Cardiac Device Clinic Success

Cardiac monitoring devices are constantly evolving, generating continuous streams of new data. Therefore, maintaining the integrity of data used by cardiac device clinic staff is mission-critical, particularly when clinics transition between legacy and next-generation cardiac device management platforms.

New platforms must seamlessly integrate CIED data from any cardiac device manufacturer’s system to provide clinicians with vital and accurate information. MURJ has successfully completed over 254 integrations with healthcare systems, encompassing more than 720,000 patients.

Integration teams should possess vast experience across multiple systems. These experts work directly with the cardiac clinic and IT team through planning, setup, and implementation. They also manage the back-end work to collect and integrate patient records into a new, clean data package to populate the new CIED system.

Regardless of the systems involved, pre-launch testing is an essential component of any successful data transfer. Testing should occur in three phases and include end-user acceptance of the migrated data. Random checks are crucial to verify data completeness and accuracy, ensuring all critical information is correctly transferred and readily available. Finally, clinics and IT teams should anticipate and budget for manual reviews as part of the overall project cost to ensure the highest level of data quality and patient safety.

The ultimate goal for hospital and health system IT teams is to empower clinicians with all the data they need to operate at the top of their license and without incident. By safely integrating all necessary data into a central cardiac device monitoring platform, IT teams become an essential partner in the cardiac device clinic’s overall success.

About Christy Bricker 

Christy Bricker, CPHIMS, is a proven health information technology leader with over 30 years of experience serving in IT roles for the University of Kentucky, Catholic Health Initiatives,  and Baptist Health System. She now leads strategic services at MURJ, an innovator in cardiac device management, where she uses her vast experience with EHRs to elevate cardiac patient care for MURJ health system and cardiac clinic customers. 



< + > Datavant Completes Acquisition of Ontellus

Datavant, the data collaboration platform trusted for healthcare, today announced the successful completion of its acquisition of Ontellus, a leading provider of health records retrieval and claims intelligence.

With this acquisition, Datavant will establish a fourth business vertical, Legal & Insurance, focused on simplifying the secure, compliant exchange of clinical and billing data between providers and requesters, including legal and insurance professionals. Vince Cole, former Ontellus CEO, will lead this new business, reporting directly to Kyle Armbrester, Datavant CEO.

“Every hour we can save from the task of exchanging health records is an hour that can be used for patient care. By bringing together Datavant and Ontellus, we will transform what has been a largely manual, time-consuming process for both making and fulfilling health record requests to a more efficient, digital process that allows providers and requesters to spend more time on higher-value activities,” said Kyle Armbrester, Datavant CEO.

This acquisition supports Datavant’s focus on moving health data securely and compliantly from where it sits to where it needs to be in the right format to authorized users. Ontellus has also been pursuing this objective on behalf of record requestors by digitizing its records retrieval business into a nationwide platform through which record requesters have direct access to providers. Additionally, through its canvassing services, Ontellus delivers detailed claimant treatment timelines to validate claims or uncover preexisting conditions, helping insurance customers reduce unnecessary and costly claims exposure.

“The Ontellus team has built a technology platform and scaled service offerings that are trusted by legal and insurance professionals across the country, and I am confident that through Vince’s leadership, we will be able to leverage the spectrum of our expertise and capabilities to benefit all of our clients,” said Armbrester.

About Datavant

Datavant is the data collaboration platform trusted for healthcare. With a mission to make the world’s health data secure, accessible, and actionable, Datavant works with payers, providers, life sciences, legal, and insurance clients globally to accelerate insights. Datavant enables more than 60 million healthcare records to move between thousands of organizations across the healthcare ecosystem, more than 80,000 hospitals and clinics, 75% of the 100 largest health systems, and 300+ real-world data partners. Datavant has office locations in Boston, New York, and San Diego, with international offices in Barcelona and Galway. To learn more about Datavant, visit datavant.com and follow us on LinkedIn.

About Ontellus

Ontellus empowers insurance carriers, self-insured corporations, and law firms to reduce costs, make informed decisions, and accelerate claims resolution. As one of the nation’s largest, privately held data retrieval and claims intelligence providers, Ontellus leverages decades of experience and cutting-edge technology to deliver impactful products and client-centric services with industry-leading turnaround times. For more information, visit ontellus.com.

Originally announced August 6th, 2025



Monday, August 25, 2025

< + > Bridging the Gap Between Hospital Data and Medical AI

The following is a guest article by Benji Meltzer, Chief Data Officer at Gradient Health

Reliable data is the foundation for building, testing, and validating the tools that will shape the next century of healthcare. From detecting early-stage disease to predicting complications, these tools depend on real-world data to perform safely. Without enough relevant data, progress stalls, models become brittle, biased, and clinically irrelevant. And the gap between AI potential and actual patient outcomes widens.

The Risks of Sharing and Not Sharing  

For many health systems, the conversation about data sharing stops at the risks: regulatory uncertainty, ethical concerns, and the operational burden of making the data available. Those are valid concerns. But they’re only half the equation.

But there’s also a risk in doing nothing.

When healthcare systems opt out of data sharing, they risk their patient population being left out of the datasets that shape tomorrow’s diagnostic tools. That means their patients are less likely to be represented in medical AI models. It means tools may not generalize to their workflows or patient demographics.

The ethical obligation isn’t just about privacy. It’s also about equity. If we don’t include broad, diverse patient data in AI development, we build systems that serve the few, not the many.

Reward Matters  

Research shows that incentives matter when it comes to data sharing. Misalignment with mission, unclear value, or lack of upside all dampen willingness to participate, even when the risk is low.

Yes, financial rewards like revenue-sharing models help, especially when data sharing supports longer-term sustainability. But the most compelling motivator is impact. Systems that share data help shape innovations that directly benefit their patients. They become part of the development loop. They contribute to tools that reflect their populations, reduce misdiagnosis, and improve care quality across the board.

That’s a real, lasting reward for all involved.

The Operational Reality  

Of course, intention isn’t the only barrier. Infrastructure and resource limitations are real.  

Extracting usable data from fragmented and disconnected legacy systems is hard, particularly given the amount of vendor lock-in that exists in our sector, preventing data from being shared at will. De-identifying it to meet regulatory standards can be even harder, and sharing it in a way that supports research, while avoiding custom integrations with dozens of AI developers, can quickly become a full-time job. This is where the model needs to evolve.

Rather than each health system maintaining one-off agreements with every AI company, a more scalable approach is to work through data intermediaries. These groups specialize in taking fragmented, real-world data and turning it into something usable, namely: structured, de-identified, quality-controlled, research-ready, and ethics-governed datasets.

Companies like Gradient Health and others help reduce the operational burden while ensuring that health systems remain in control of how their data is used. It’s less about outsourcing responsibility and more about enabling participation without creating another IT project for data providers.

What to Look for in a Data Intermediary  

If a health system chooses to work with a data partner, it matters who they trust. A good intermediary should:  

  • Have a track record of successful data collaborations with health systems and research groups
  • Meet high standards for privacy, de-identification, and data governance
  • Offer clear, ethical oversight of research projects
  • Understand how to curate datasets that reflect real clinical complexity, not just clean cases
  • Provide infrastructure that integrates with, rather than complicates, existing IT systems

The goal is to make data sharing safer, easier, and more aligned with the mission of care delivery.

Closing the Gap  

Medical AI will only be as good as the data it’s built on. And right now, the best data is sitting in hospitals and outpatient imaging centers across the world, underused, undershared, and often overlooked.

We have the technical tools, the regulatory frameworks, and the relationships to make responsible data sharing possible. What’s needed now is leadership: from imaging executives, CIOs, CMIOs, and others who see that shaping the future of healthcare starts with how we treat the data we already have.

Doing nothing is a choice. And it carries risk.

Doing something, carefully, responsibly, and with the right partners, could shape the next generation of care.   

About Benji Meltzer

Benji Meltzer is the Chief Data Officer at Gradient Health, global experts at connecting health systems wanting to share data to responsible AI developers who need it.



< + > Capsa Healthcare Acquires BlueBin to Advance Intelligent Clinical Supply Management

Strategic Acquisition Integrates Predictive Analytics and Kanban Methodology with Point-of-Care Solutions to Streamline Supply Operations and Support Clinical Care Delivery

Capsa Healthcare, a leader in healthcare workflow and supply management solutions, today announced the acquisition of BlueBin, a recognized innovator in Kanban-based supply chain systems and predictive analytics for healthcare. This strategic move brings together two complementary capabilities that together enhance visibility, efficiency, and reliability across the entire clinical supply chain.

By integrating BlueBin’s proven methodologies and analytics with Capsa’s point-of-care and supply management technologies, the combined solution aims to reduce operational friction, improve supply availability, and return valuable time to clinical teams.

“Healthcare systems are under increasing pressure to do more with less—clinically, operationally, and financially,” said Gaurav Agarwal, Chief Executive Officer at Capsa Healthcare. “This acquisition reflects our continued commitment to developing intelligent infrastructure that equips, enables, and engineers solutions to free up clinical care and deliver measurable financial results.”

BlueBin’s solutions are currently deployed in over 250 hospitals, with a strong track record of client retention and operational impact. At Memorial Hermann Health System, BlueBin’s Kanban implementation led to $4 million in annual supply savings and an additional $2.4 million in operational efficiencies.

The BlueBin acquisition reinforces Capsa’s capability to optimize healthcare operations, reduce waste, and enhance patient care.

  • Clinical Focus: Reduces the time clinicians spend on supply-related tasks, allowing more time for patient care
  • Operational Visibility: Provides real-time data on inventory levels and usage patterns
  • Financial Efficiency: Helps reduce supply costs and optimize inventory levels
  • Space Utilization: Minimizes storage footprint, freeing up space for clinical use

BlueBin’s leadership and implementation model will remain in place, with Charles Hodge continuing as President and CEO. His team’s hands-on, community-based approach to implementation will ensure continuity and success for current and future clients.

“This partnership allows us to scale our mission of ensuring the right supplies reach the right place at the right time,” said Hodge. “Together with Capsa, we’re building a smarter, more responsive supply chain that supports both caregivers and patients.”

With this acquisition, Capsa Healthcare becomes the only provider offering a complete clinical supply management solution—from warehouse to bedside—through a single partner.

About Capsa Healthcare

Capsa Healthcare is a global provider of innovative workflow solutions for healthcare delivery. With over 60 years of experience, Capsa designs and delivers technology-enabled products that improve efficiency, safety, and care outcomes. Learn More →

About BlueBin

BlueBin is a pioneer in Kanban-based hospital supply management, offering predictive analytics and Lean transformation services. With a presence in over 250 hospitals, BlueBin helps healthcare systems reduce waste, lower costs, and ensure supply availability at the point of care. Learn more at BlueBin | Healthcare Supply Chain & Inventory Management

Originally announced July 31st, 2025



< + > Hybrid Intelligence with Carta Healthcare – Life Sciences Today Podcast Episode 33

We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Aaron Brauser, Ge...